165 related articles for article (PubMed ID: 10571026)
21. Hemolytic-uremic syndrome associated with an infection by verotoxin producing Escherichia coli 0111 in a woman on oral contraceptives.
Stenger KO; Windler F; Karch H; von Wulffen H; Heesemann J
Clin Nephrol; 1988 Mar; 29(3):153-8. PubMed ID: 3282732
[TBL] [Abstract][Full Text] [Related]
22. Two distinct binding sites for globotriaosyl ceramide on verotoxins: identification by molecular modelling and confirmation using deoxy analogues and a new glycolipid receptor for all verotoxins.
Nyholm PG; Magnusson G; Zheng Z; Norel R; Binnington-Boyd B; Lingwood CA
Chem Biol; 1996 Apr; 3(4):263-75. PubMed ID: 8807854
[TBL] [Abstract][Full Text] [Related]
23. Association of verotoxin-producing E. coli and verotoxin with hemolytic uremic syndrome.
Arbus GS
Kidney Int Suppl; 1997 Mar; 58():S91-6. PubMed ID: 9067954
[TBL] [Abstract][Full Text] [Related]
24. Influence of phospholipid chain length on verotoxin/globotriaosyl ceramide binding in model membranes: comparison of a supported bilayer film and liposomes.
Arab S; Lingwood CA
Glycoconj J; 1996 Apr; 13(2):159-66. PubMed ID: 8737240
[TBL] [Abstract][Full Text] [Related]
25. Expression of the verotoxin receptor glycolipid, globotriaosylceramide, in ovarian hyperplasias.
Arab S; Russel E; Chapman WB; Rosen B; Lingwood CA
Oncol Res; 1997; 9(10):553-63. PubMed ID: 9507533
[TBL] [Abstract][Full Text] [Related]
26. Acidic pH changes receptor binding specificity of Helicobacter pylori: a binary adhesion model in which surface heat shock (stress) proteins mediate sulfatide recognition in gastric colonization.
Huesca M; Borgia S; Hoffman P; Lingwood CA
Infect Immun; 1996 Jul; 64(7):2643-8. PubMed ID: 8698490
[TBL] [Abstract][Full Text] [Related]
27. Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits.
Bast DJ; Brunton JL; Karmali MA; Richardson SE
Infect Immun; 1997 Jun; 65(6):2019-28. PubMed ID: 9169727
[TBL] [Abstract][Full Text] [Related]
28. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome.
van de Kar NC; Monnens LA; Karmali MA; van Hinsbergh VW
Blood; 1992 Dec; 80(11):2755-64. PubMed ID: 1333300
[TBL] [Abstract][Full Text] [Related]
29. Association between hemolytic uremic syndrome and verotoxin-producing strains of E. coli.
Jure MA; de Saab OA; de Castillo MC; Sesma F; Miceli S; Zamora AM; de Ruiz Holgado AP; de Nader OM
Rev Latinoam Microbiol; 1998; 40(1-2):1-8. PubMed ID: 10932728
[TBL] [Abstract][Full Text] [Related]
30. Polyisobutylmethacrylate modifies glycolipid binding specificity of verotoxin 1 in thin-layer chromatogram overlay procedures.
Yiu SC; Lingwood CA
Anal Biochem; 1992 Apr; 202(1):188-92. PubMed ID: 1621981
[TBL] [Abstract][Full Text] [Related]
31. Localization of verotoxin receptors in nervous system.
Ren J; Utsunomiya I; Taguchi K; Ariga T; Tai T; Ihara Y; Miyatake T
Brain Res; 1999 Apr; 825(1-2):183-8. PubMed ID: 10216186
[TBL] [Abstract][Full Text] [Related]
32. CD19 has a potential CD77 (globotriaosyl ceramide)-binding site with sequence similarity to verotoxin B-subunits: implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis.
Maloney MD; Lingwood CA
J Exp Med; 1994 Jul; 180(1):191-201. PubMed ID: 7516406
[TBL] [Abstract][Full Text] [Related]
33. Phenylalanine 30 plays an important role in receptor binding of verotoxin-1.
Clark C; Bast D; Sharp AM; St Hilaire PM; Agha R; Stein PE; Toone EJ; Read RJ; Brunton JL
Mol Microbiol; 1996 Feb; 19(4):891-9. PubMed ID: 8820657
[TBL] [Abstract][Full Text] [Related]
34. Verotoxin glycolipid receptors determine the localization of microangiopathic process in rabbits given verotoxin-1.
Zoja C; Corna D; Farina C; Sacchi G; Lingwood C; Doyle MP; Padhye VV; Abbate M; Remuzzi G
J Lab Clin Med; 1992 Aug; 120(2):229-38. PubMed ID: 1323633
[TBL] [Abstract][Full Text] [Related]
35. Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide.
Waddell T; Cohen A; Lingwood CA
Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7898-901. PubMed ID: 2236008
[TBL] [Abstract][Full Text] [Related]
36. Susceptibility to verotoxin as a function of the cell cycle.
Pudymaitis A; Lingwood CA
J Cell Physiol; 1992 Mar; 150(3):632-9. PubMed ID: 1537890
[TBL] [Abstract][Full Text] [Related]
37. Effect of globotriaosyl ceramide fatty acid alpha-hydroxylation on the binding by verotoxin 1 and verotoxin 2.
Binnington B; Lingwood D; Nutikka A; Lingwood CA
Neurochem Res; 2002 Aug; 27(7-8):807-13. PubMed ID: 12374217
[TBL] [Abstract][Full Text] [Related]
38. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.
Watanabe M; Matsuoka K; Kita E; Igai K; Higashi N; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K
J Infect Dis; 2004 Feb; 189(3):360-8. PubMed ID: 14745692
[TBL] [Abstract][Full Text] [Related]
39. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro.
Lingwood CA; Law H; Richardson S; Petric M; Brunton JL; De Grandis S; Karmali M
J Biol Chem; 1987 Jun; 262(18):8834-9. PubMed ID: 3298243
[TBL] [Abstract][Full Text] [Related]
40. Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric disease.
Cohen A; Madrid-Marina V; Estrov Z; Freedman MH; Lingwood CA; Dosch HM
Int Immunol; 1990; 2(1):1-8. PubMed ID: 1965141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]